Elder Care: A Resource for Interprofessional Providers: Hyperlipidemia in Older Adults: To Treat or Not to Treat?
University of Arizona College of Medicine
University of Arizona College of Medicine
Sponsor:
Donald W. Reynolds Foundation
Geriatric Education Center (GEC)
POGOe Id:
20693
Posted:
07/26/2014
Updated:
12/15/2010
http://www.reynolds.med.arizona.edu/EduProducts/ElderCareProviderSheets.cfmAbstract:
Hyperlipidemia in Older Adults: To Treat or Not to Treat? is one of a continuing series of practical, evidence based, Provider Fact Sheets which summarize key geriatric topics and provide clinically useful assessments and interventions. Initially developed for remote, rural clinical sites, they are useful for students and health care professionals from many fields and across a very broad range of health care settings.
Educational objectives:
Objectives:
1. State whether or not lipid-lowering therapy have benefit for reducing the rate of coronary events in older adults
2. Identify the statin that have the lowest and highest risk of causing rhabdomyolysis
3. Describe the significance of low cholesterol levels in frail older adults
Additional information/Special implementation requirements or guidelines:
Subscribers to POGOe are free to reprint Elder Care on their own stationery or in other publications without obtaining specific permission, so long as
- content is not changed,
- no one is charged a fee to use or read the publication,
- authors and their affiliated institutions are noted without change, and
- the reprint includes the following statement: “Reprinted courtesy of the Arizona Reynolds Program of Applied Geriatrics and the Arizona Geriatric Education Center."
Main Topics:
Intended learner audience:
Minimum geriatric competencies:
Learning resource types:
Discipline/specialty:
Estimated time to complete:
30 minutes
Contact person/corresponding author:
Lisa O'Neill: [email protected]
Suggested Citation:
Dr. Carol Howe and Dr. Barry Weiss. Elder Care: A Resource for Interprofessional Providers: Hyperlipidemia in Older Adults: To Treat or Not to Treat?. POGOe - Portal of Geriatrics Online Education; 2014 Available from: http://www.pogoe.org/productid/20693
Comments
I think this is a succinct
I think this is a succinct summary of the positive aspects of treating hyperlipidemia in older adults. I'm concerned that beside the myopathy other potential negative effects of statins were not discussed; nor was the fact that in the PROSPER trial the Mortality in the 70-82 year old age group was essentially the same (10.3% treatment, 10.5% control) with the cancer mortality being higher in the treatment group and nearly equivalent to the CAD mortality in the control group.